Tweet Archive for November 2019 « page 6
The methylisothiazolinone epidemic goes along with changing patients’ characteristics – After cosmetics industrial…
https://twitter.com/i/web/status/1196490200790097922
RT @ducrest: @imcascongress @HubertZajicek @HWildCatters @Cutera @galderma @nextmotion_ @revance FYI @AdvancingDerm & @MOAsandiego
This is…
@imcascongress @HubertZajicek @HWildCatters @Cutera @galderma @nextmotion_ @revance FYI @AdvancingDerm &…
https://twitter.com/i/web/status/1196488236606066689
RT @imcascongress: Last call for #startups! Bring your innovative solutions in dermatology, plastic surgery or aesthetics to stage during t…
The increase uses of Tranexamic acid in dermatology (off label): including systemic and intradermal use in #melasma…
https://twitter.com/i/web/status/1196321631037247490
RT @SeemalRDesaiMD: #Skin #disease, in particular #pigment issues are one of the major reasons patients with @SkinOfColor seek the care of…
The post-antibiotic era is here vox.com/future-perfect… via @voxdotcom #dermatology #dermatologia #AntibioticResistance
RT @lemonsand: I wrote about my complicated feelings re: the skincareaddiction subreddit onezero.medium.com/reddits-r-skin…
RT @AdeAdamson: Had a chance to interview the authors of this study on the @JAMADerm pocast: bit.ly/2pfiUJS
#Publichealth efforts may be favorably impacting #melanoma incidence in the US https://t.co/KHsFOfdrfa
— JAMA Dermatology (@JAMADerm) November 13, 2019